Company: INDP
Filing Date: 2025-02-12
Form Type: S-1
Source: 0001493152-25-006068
Chunk: 159

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-02-12
Form: S-1
Chunk 159
---
 increase on January 1 of each calendar year beginning on January 1, 2022 and ending on and including January 1, 2024 (each, an “Evergreen Date”), in an amount equal to the lesser of (i) 3% of the total number of shares of common stock outstanding on the December 31st immediately preceding the applicable Evergreen Date and (ii) such lesser number of shares of common stock as determined to be appropriate by the Committee (as defined in the 2021 Plan) in its sole discretion. On January 1, 2022, January 1, 2023 and January 1, 2024 the Pool was increased by 247,758shares, 252,031shares and 252,031shares, respectively. In no event shall more than 1,864,963shares be available for issuance for Incentive Stock Options (as defined in the 2021 Plan) under the 2021 Plan.

| F-11 |

The 2021 Plan provides for the grant of non-qualified stock options, incentive stock options, restricted stock awards, restricted stock units, unrestricted stock awards, stock appreciation rights and other forms of stock-based compensation. The 2021 Plan permits the Company’s board to change the type, terms and conditions of awards as circumstances may change. This flexibility to adjust the type of compensation to be granted is particularly important given current economic and world events.

A summary of the stock option activity during the year ended December 31, 2023, is presented in the table below:

SCHEDULE OF STOCK OPTION ACTIVITY

|                                                     |     | Number of 
 options   |           |   |     | Weighted average 
 Exercise         
 price            |       |     | Remaining   
 contractual 
 life        
 (in years)  |     |     | Intrinsic value |        |
|:----------------------------------------------------|:----|:----------|----------:|:--|:----|:-----------------|------:|:----|:------------|----:|:----|:----------------|-------:|
| Outstanding as of January 1, 2023                   |     |           | 1,672,873 |   |     | $                | 13.01 |     |             | 8.5 |     | $               |      - |
| Granted                                             |     |           |   425,750 |   |     | $                |  1.70 |     |             |   - |